INDSWFTLTDNSEInd-Swift Limited· PharmaceuticalsHighNeutral
Announced Thu, 17 Jul · 19:25 IST

We hereby inform that the Hon'ble National Company Law Tribunal ( NCLT ), Chandigarh Bench has vide its order dated July 17, 2025 approved the Scheme of Arrangement for Amalgamation of Ind-Swift Limited with Ind Swift Laboratories Limited.

Nclt Scheme FiledStrategic Transactions View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The National Company Law Tribunal (NCLT), Chandigarh Bench has approved the Scheme of Arrangement for the amalgamation of Ind-Swift Limited (the Transferor Company) with Ind-Swift Laboratories Limited (the Transferee Company), along with their respective shareholders and creditors. The order was pronounced on July 17, 2025, under Sections 230 and 232 of the Companies Act, 2013, with an Appointed Date of March 31, 2024. Upon the scheme becoming effective (after filing the certified copy of the NCLT order with the Registrar of Companies), Ind-Swift Limited will stand dissolved without winding up. A certified copy of the order is awaited, and further updates will be shared in due course.

Likely market impact

For Ind-Swift Limited shareholders, this is a significant corporate event: the company will be merged into Ind-Swift Laboratories Limited, and shares of Ind-Swift Limited will eventually stand cancelled in exchange for shares of the Transferee Company. Shareholders should watch for the swap ratio announcement and the effective date, as the stock may see re-rating or trading adjustments around that time.